EAT is up +49.38%% since April’24 pick View All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RENB
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Renovaro Biosciences Inc. stock price on Friday moving between $1.45 and $1.79
(Updated on Jun 28, 2024)

Buy candidate since Jun 28, 2024 PDF

The Renovaro Biosciences Inc. stock price gained 16.67% on the last trading day (Friday, 28th Jun 2024), rising from $1.50 to $1.75. During the last trading day the stock fluctuated 23.45% from a day low at $1.45 to a day high of $1.79. The price has been going up and down for this period, and there has been a 20.69% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 5 million more shares were traded than the day before. In total, 6 million shares were bought and sold for approximately $10.01 million.

Given the current short-term trend, the stock is expected to fall -42.62% during the next 3 months and, with a 90% probability hold a price between $0.178 and $1.00 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

RENB Signals & Forecast

The Renovaro Biosciences Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.58 and $1.35. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, May 16, 2024, and so far it has risen 90.78%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Renovaro Biosciences Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.57 and $1.49. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Renovaro Biosciences Inc. finds support just below today's level at $1.57. If this is broken, then the next support from accumulated volume will be at $1.49 and $1.32.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.340 between high and low, or 23.45%. For the last week, the stock has had daily average volatility of 13.70%.

Our recommended stop-loss: $1.69 (-3.62%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 67 days ago.)

Trading Expectations (RENB) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Renovaro Biosciences Inc. to open at $1.66, and during the day (based on 14 day Average True Range), to move between $1.50 and $2.00, which gives a possible trading interval of +/-$0.254 (+/-14.52%) up or down from last closing price. If Renovaro Biosciences Inc. takes out the full calculated possible swing range there will be an estimated 29.04% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.57 (10.29%) than the resistance at $1.97 (12.57%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Renovaro Biosciences Inc. stock A Buy?

Renovaro Biosciences Inc. holds several positive signals and despite the stock being in a falling trend, we considered it to be a good choice at these current levels. We expect Renovaro Biosciences Inc. stock will perform very well in the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Buy candidate.

Current score: 5.875 Strong Buy Candidate Upgraded

Predicted Opening Price for Renovaro Biosciences Inc. of Monday, July 1, 2024

Fair opening price July 1, 2024 Current price
$1.66 ( 4.95%) $1.75

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for RENB

Fibonacci Support & Resistance Levels

Level Price
R3 2.00 14.48%
R2 1.87 7.05%
R1 1.79 2.47%
Price 1.75
S1 1.53 -12.37%
S2 1.45 -16.96%
S3 1.32 -24.38%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.17 24.00%
R2 2.02 15.43%
R1 1.97 12.57%
Price 1.75
S1 1.57 -10.29%
S2 1.49 -14.86%
S3 1.32 -24.57%

FAQ

What is the symbol for Renovaro Biosciences Inc. Stock and on which exchange is it traded?
The symbol for Renovaro Biosciences Inc. is RENB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Renovaro Biosciences Inc. Stock?
Renovaro Biosciences Inc. holds several positive signals and despite the stock being in a falling trend, we considered it to be a good choice at these current levels. We expect Renovaro Biosciences Inc. stock will perform very well in the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Buy candidate.

How to buy Renovaro Biosciences Inc. Stock?
Renovaro Biosciences Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Renovaro Biosciences Inc. Stock.

What's the current price of Renovaro Biosciences Inc. Stock?
As of the end of day on the Jun 28, 2024, the price of an Renovaro Biosciences Inc. (RENB) share was $1.75.

What is the 52-week high and low for Renovaro Biosciences Inc. Stock?
The 52-week high for Renovaro Biosciences Inc. Stock is $5.25 and the 52-week low is $0.393.

What is the market capitalization of Renovaro Biosciences Inc. Stock?
As of the Jun 28, 2024, the market capitalization of Renovaro Biosciences Inc. is 269.371M.

When is the next earnings date for Renovaro Biosciences Inc.?
The upcoming earnings date for Renovaro Biosciences Inc. is Sep 30, 2024.
Click to get the best stock tips daily for free!